BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 18380444)

  • 1. Testing the hypothesis that selenium deficiency is a risk factor for clozapine-induced agranulocytosis in rats.
    Ip J; Uetrecht JP
    Chem Res Toxicol; 2008 Apr; 21(4):874-8. PubMed ID: 18380444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing the hypothesis that vitamin C deficiency is a risk factor for clozapine-induced agranulocytosis using guinea pigs and ODS rats.
    Ip J; Wilson JX; Uetrecht JP
    Chem Res Toxicol; 2008 Apr; 21(4):869-73. PubMed ID: 18380445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of clozapine and olanzapine on neutrophil kinetics: implications for drug-induced agranulocytosis.
    Ng W; Kennar R; Uetrecht J
    Chem Res Toxicol; 2014 Jul; 27(7):1104-8. PubMed ID: 24968069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolic formation of reactive intermediates from clozapine, a drug associated with agranulocytosis in man.
    Maggs JL; Williams D; Pirmohamed M; Park BK
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1463-75. PubMed ID: 8531117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential role of a quetiapine metabolite in quetiapine-induced neutropenia and agranulocytosis.
    Li X; Cameron MD
    Chem Res Toxicol; 2012 May; 25(5):1004-11. PubMed ID: 22506851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clozapine-induced agranulocytosis. Incidence and risk factors in the United States.
    Alvir JM; Lieberman JA; Safferman AZ; Schwimmer JL; Schaaf JA
    N Engl J Med; 1993 Jul; 329(3):162-7. PubMed ID: 8515788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of clozapine on neutrophil kinetics in rabbits.
    Iverson S; Kautiainen A; Ip J; Uetrecht JP
    Chem Res Toxicol; 2010 Jul; 23(7):1184-91. PubMed ID: 20553052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of clozapine-associated agranulocytosis and mandatory white blood cell monitoring.
    Schulte P
    Ann Pharmacother; 2006 Apr; 40(4):683-8. PubMed ID: 16595571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine: the commitment to patient safety.
    Alphs LD; Anand R
    J Clin Psychiatry; 1999; 60 Suppl 12():39-42. PubMed ID: 10372610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cytotoxicity of clozapine metabolites: implications for predicting clozapine-induced agranulocytosis.
    Tschen AC; Rieder MJ; Oyewumi LK; Freeman DJ
    Clin Pharmacol Ther; 1999 May; 65(5):526-32. PubMed ID: 10340918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human leukocyte antigen typing, response to neuroleptics, and clozapine-induced agranulocytosis in jewish Israeli schizophrenic patients.
    Meged S; Stein D; Sitrota P; Melamed Y; Elizur A; Shmuelian I; Gazit E
    Int Clin Psychopharmacol; 1999 Sep; 14(5):305-12. PubMed ID: 10529073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible role of free radical formation in clozapine (clozaril)-induced agranulocytosis.
    Fischer V; Haar JA; Greiner L; Lloyd RV; Mason RP
    Mol Pharmacol; 1991 Nov; 40(5):846-53. PubMed ID: 1658615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High clozapine concentrations in leukocytes in a patient who developed leukocytopenia.
    Bergemann N; Abu-Tair F; Aderjan R; Kopitz J
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1068-71. PubMed ID: 17467133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clozapine-induced agranulocytosis: genetic risk factors and an immunologic explanatory model].
    Güzelcan Y; Scholte WF
    Tijdschr Psychiatr; 2006; 48(4):295-302. PubMed ID: 16955993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clozapine bioactivation induces dose-dependent, drug-specific toxicity of human bone marrow stromal cells: a potential in vitro system for the study of agranulocytosis.
    Pereira A; Dean B
    Biochem Pharmacol; 2006 Sep; 72(6):783-93. PubMed ID: 16844094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased apoptosis of neutrophils in a case of clozapine-induced agranulocytosis - a case report.
    Loeffler S; Fehsel K; Henning U; Fischer J; Agelink M; Kolb-Bachofen V; Klimke A
    Pharmacopsychiatry; 2003 Jan; 36(1):37-41. PubMed ID: 12649775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Filgrastim treatment of three patients with clozapine-induced agranulocytosis.
    Lamberti JS; Bellnier TJ; Schwarzkopf SB; Schneider E
    J Clin Psychiatry; 1995 Jun; 56(6):256-9. PubMed ID: 7539786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil cytotoxicity of the chemically reactive metabolite(s) of clozapine: possible role in agranulocytosis.
    Williams DP; Pirmohamed M; Naisbitt DJ; Maggs JL; Park BK
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1375-82. PubMed ID: 9400013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term patient monitoring for clozapine-induced agranulocytosis and neutropenia in Korea: when is it safe to discontinue CPMS?
    Kang BJ; Cho MJ; Oh JT; Lee Y; Chae BJ; Ko J
    Hum Psychopharmacol; 2006 Aug; 21(6):387-91. PubMed ID: 16933201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case study; ethnicity and clozapine, a risky combination?].
    Laan WJ; Ramlal D
    Tijdschr Psychiatr; 2012; 54(9):829-33. PubMed ID: 22961282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.